AARD
Aardvark TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
AARD vs peer average
95/100
AARD vs. peer average (A vs. D)
Grade spread
C 1 · D 3 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
MGX is the first available peer comparator.
Packet-supplied small-cap biotechnology size reference only; no supplied evidence establishes a matching indication, development stage, or regulatory risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AARD
Aardvark Therapeutics
MGX
Metagenomi Therapeutics
Grade
A
C
Momentum
91
21
Value
57
57
Sentiment
67
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs MGX
AARD / MGX
Grade Position
Above peers
AARD vs. peer average (A vs. D)
95/100
Momentum
91
AARDValue
57
MGXSentiment
67
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AARD
MGX is the first peer returned for this comparison set.